PhRMA revises guidelines for clinical trials

Related Products

• ePharm5 InDepth

  EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

• Business Insights: Optimizing Lifecycle Management:

  This report explains the basics of drug lifecycle and investigates three goals in optimizing product potential- expanding...

• Big Pharma Performance Before, During and Beyond the Global Recession

  This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...

Most Popular

Related Articles

• Stanford to stop accepting industry funding for CME

  Stanford became the latest academic institution to limit how much funding it will accept from pharmaceutical and medical...

• REMS represent big change for industry

  Risk Evaluation and Mitigation Strategies (REMS) could represent the biggest change to drug regulation in decades. And it...

• Cleveland Clinic, Penn Medicine to post physician ties to pharma companies

  Cleveland Clinic and the University of Pennsylvania are taking steps toward transparency regarding physicians’ ties to...

• Credentialing requirements continue to be concern for industry

  The relationship between the surgeon and the sales representative is vital to patient care. However, medical device...

• PhRMA releases new DTC advertising guidelines

  Five months after updating its Code on Interactions with Healthcare Professionals, the Pharmaceutical Research and...